Defense Backlog And Vertical Integration Will Drive Rocket Lab Toward $85 Despite Neutron Execution Risk

Key Takeaways

• Rocket Lab is mid-transformation from a small-launch specialist into a vertically integrated space and defense prime, with Space Systems now ~67% of revenue and growing fastest.
• A $1.85B backlog (+73% YoY) anchored by the $816M SDA Tranche 3 award provides multi-year revenue visibility that the current trailing P/S of ~72x doesn't yet fully reflect.
• Neutron's Q4 2026 maiden flight is the binary catalyst — success unlocks the medium-lift TAM, while another slip would compress the multiple meaningfully.
• My fair value estimate is $85 per share, modestly above the recent $74.68 trading price and broadly in line with Wall Street consensus (~$87).

Catalysts

The defense pivot is the most underappreciated part of this story. Combined SDA Tranche 2 and Tranche 3 awards now exceed $1.3B, and management disclosed on the Q4 2025 call that these contracts convert on a 10/40/40/10 schedule. That means the bulk of the $816M Tranche 3 award won't hit revenue until 2027 and 2028 — investors modelling on TTM revenue are looking at the wrong number entirely. Rocket Lab is increasingly being treated as a credible alternative prime contractor by the Department of War, and Golden Dome and follow-on PWSA tranches represent a structurally expanding TAM.

Neutron transforms the launch business from niche to mainstream. Electron is a profitable but capacity-constrained small-launch vehicle (199M in 2025 launch revenue from 21 missions). Neutron — a reusable, 13-tonne medium-lift rocket — opens up large constellation deployment, NSSL competition, and potentially cargo missions. The stage 1 tank failure pushed the maiden flight to Q4 2026, but the company's pivot to automated fiber placement should produce a more manufacturable airframe long-term.

Vertical integration is compounding margin leverage. The Mynaric acquisition (laser optical communications, closed April 2026), plus the new in-house Gauss electric thruster and the earlier Geost optical payload deal, mean Rocket Lab now controls more of its bill of materials. Q4 2025 GAAP gross margin reached 38% (up 100bps sequentially) and non-GAAP hit 44.3% — a trajectory I expect to continue as Space Systems scales.

The Meta space-based solar partnership is small today but signals that hyperscalers are starting to view Rocket Lab as the go-to constellation manufacturer for non-traditional space applications.

Assumptions

Revenue: I model revenue growing from $601.8M in 2025 to ~$2.4B by 2029, a ~41% CAGR. This assumes Q1 2026 lands at the high end of guidance ($200M), full-year 2026 of ~$900M (consistent with analyst consensus), then acceleration in 2027–2028 as SDA Tranche 2/3 deliveries hit peak conversion. Neutron contributes meaningfully only from 2027 onward — I'm conservatively modelling 4 launches in 2027 and 8 in 2028.

Margins: GAAP gross margin expands from ~30% in 2025 to 38–40% by 2028 as Space Systems scale and vertical integration take hold. Adjusted EBITDA crosses breakeven in late 2027, with a path to 15%+ EBITDA margins by 2029 as fixed-cost absorption improves.

Multiple: RKLB currently trades at ~72x trailing sales, which is unsustainable. By 2029, with revenue near $2.4B and EBITDA approaching $350M, I assume the market re-rates to an EV/Sales of ~22x (in line with mature aerospace primes plus a high-growth premium) or roughly 45x EV/EBITDA.

Share count: ~620M diluted shares by 2029 (modest dilution from continued equity-based comp and the Series A convertible preferreds).

Discount rate: 10.5% — reflecting elevated execution risk on Neutron and the early-stage nature of much of the revenue base.

Running this through a scenario-weighted DCF (40% base / 35% bear / 25% bull), I arrive at a fair value of $85 per share, implying ~14% upside from $74.68. The bull case ($110+) requires Neutron to fly cleanly in 2026 and capture meaningful NSSL share by 2028; the bear case ($55) assumes a 12-month Neutron slip and SDA conversion delays.

Risks

Neutron is the dominant near-term risk. Another tank failure, a launch anomaly, or further slippage into 2027 would not only delay the launch revenue ramp but likely trigger multiple compression as the bull thesis loses its anchor. The market has already partially priced this risk in via the 25% drawdown from January's $99.58 high.

Cash burn and dilution. Trailing EBITDA is roughly -$185M, and Q1 2026 guidance points to another $21–27M adjusted EBITDA loss. Cash and equivalents sit above $1B, so liquidity is not an immediate concern, but a longer path to profitability than I'm modelling could force another capital raise. The 46M Series A convertible preferreds are already in the diluted share count.

Customer concentration. SDA contracts are an enormous tailwind, but they also concentrate the revenue base in a single customer relationship — and U.S. defense priorities can shift with administrations.

Competition. SpaceX continues to widen the gap on raw launch capacity, and a successful SpaceX IPO could either lift the sector (rising tide) or redirect capital away from RKLB toward the bigger, more proven name.

Valuation itself is a risk. Even at a fair-value-aligned $85, RKLB trades at a multiple that requires near-flawless execution. Any wobble — from a customer delay to a missed quarter — has historically produced 15%+ single-day drawdowns.

Conclusion

Rocket Lab is no longer a launch company that happens to make satellite components — it's a vertically integrated space prime that's increasingly valued on its defense backlog and Space Systems franchise. The current $74.68 price already reflects a great deal of optimism, but I believe the 2027–2028 revenue ramp from SDA conversions, combined with margin expansion from vertical integration, supports a fair value of $85.

I'd be a more aggressive buyer below $65 (a clear discount to the base case) and would trim above $100 unless Neutron has flown successfully and the margin trajectory exceeds my assumptions. At today's price, the stock looks modestly undervalued but priced for execution — appropriate for a position size that reflects both the asymmetric upside and the binary nature of the Neutron catalyst.